tizanidine
- Product NDC
- 66267-598
- 11-digit product format
- 662670598
- Labeler code
- 66267
- Product ID
- 66267-598_9cafdd91-3c92-0e7e-e053-2a95a90a6c07
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA076533
- Marketing category
- ANDA
- Marketing start
- 2004-01-16
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66267-598-30 | 66267059830 | 30 TABLET in 1 BOTTLE (66267-598-30) | 30 tablet | 2017-03-15 | 0000-00-00 | No | No | Current |
| 66267-598-60 | 66267059860 | 60 TABLET in 1 BOTTLE (66267-598-60) | 60 tablet | 2017-03-15 | 0000-00-00 | No | No | Current |
| 66267-598-90 | 66267059890 | 90 TABLET in 1 BOTTLE (66267-598-90) | 90 tablet | 2017-03-15 | 0000-00-00 | No | No | Current |